Sauter C, Lorber B, Kern D, Cavarelli J, Moras D, Giegé R
UPR 9002, Institut de Biologie Moléculaire et Cellulaire du CNRS, 15 rue René Descartes, F 67084 Strasbourg CEDEX, France.
Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):149-56. doi: 10.1107/S0907444998010890. Epub 1999 Jan 1.
Aspartyl-tRNA synthetase (AspRS) extracted from yeast is heterogeneous owing to proteolysis of its positively charged N-terminus; its crystals are of poor quality. To overcome this drawback, a rational strategy was developed to grow crystals of sufficient quality for structure determination. The strategy is based on improvement of the protein homogeneity and optimization of crystallization, taking advantage of predictions from crystal-growth theories. An active mutant lacking the first 70 residues was produced and initial crystallization conditions searched. The shape and habit of initial crystals were improved by establishing a phase diagram of protein versus crystallizing-agent concentrations. Growth of large well faceted crystals takes place at low supersaturations near the isochronic supersolubility curve. Further refinement led to reproducible growth of two crystalline forms of bipyramidal (I) or prismatic (II) habit. Both diffract X-rays better than crystals previously obtained with native AspRS. Complete data sets were collected at 3 A resolution for form I (space group P41212) and form II (space group P3221) and molecular-replacement solutions were found in both space groups.
从酵母中提取的天冬氨酰 - tRNA合成酶(AspRS)由于其带正电荷的N端被蛋白酶解而具有异质性;其晶体质量较差。为了克服这一缺点,开发了一种合理的策略来生长出质量足以用于结构测定的晶体。该策略基于提高蛋白质的均一性以及优化结晶过程,利用了晶体生长理论的预测结果。制备了一个缺失前70个残基的活性突变体,并搜索了初始结晶条件。通过建立蛋白质与结晶剂浓度的相图,改善了初始晶体的形状和习性。在等时超溶解度曲线附近的低过饱和度下会生长出大的、多面的晶体。进一步的优化使得可重复生长出两种具有双锥体(I)或棱柱体(II)习性的晶体形式。这两种晶体的X射线衍射效果都比之前用天然AspRS获得的晶体要好。以3埃分辨率收集了I型(空间群P41212)和II型(空间群P3221)的完整数据集,并且在这两个空间群中都找到了分子置换解。